Department of Medicine, University of California, Davis, California 95817, USA.
J Clin Endocrinol Metab. 2010 May;95(5):2376-83. doi: 10.1210/jc.2009-2498. Epub 2010 Mar 1.
Lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) is bound predominately to low-density lipoprotein and has been implicated as a risk factor for coronary artery disease (CAD).
We investigated the association between Lp-PLA(2) and CAD in a biethnic African-American and Caucasian population.
Lp-PLA(2) mass, activity, and index, an integrated measure of mass and activity, and other cardiovascular risk factors were determined in 224 African-Americans and 336 Caucasians undergoing coronary angiography.
We assessed the distribution of Lp-PLA(2) levels and determined the predictive role of Lp-PLA(2) as a risk factor for CAD.
Levels of Lp-PLA(2) mass and activity were higher among Caucasians compared with African-Americans (293 +/- 75 vs. 232 +/- 76 ng/ml, P < 0.001 for mass and 173 +/- 41 vs. 141 +/- 39 nmol/min/ml, P < 0.001 for activity, respectively). However, Lp-PLA(2) index was similar in the two groups (0.61 +/- 0.17 vs. 0.64 +/- 0.19, P = NS). In both ethnic groups, Lp-PLA(2) activity and index was significantly higher among subjects with CAD. African-American subjects with CAD had significantly higher Lp-PLA(2) index than corresponding Caucasian subjects (0.69 +/- 0.20 vs. 0.63 +/- 0.18, P = 0.028). In multivariate regression analyses, after adjusting for other risk factors, Lp-PLA(2) index was independently (odds ratio 6.7, P = 0.047) associated with CAD in African-Americans but not Caucasians.
Lp-PLA(2) activity and index was associated with presence of CAD among African-Americans and Caucasians undergoing coronary angiography. The findings suggest an independent impact of vascular inflammation among African-Americans as contributory to CAD risk and underscore the importance of Lp-PLA(2) as a cardiovascular risk factor.
脂蛋白相关磷脂酶 A(2)(Lp-PLA(2))主要与低密度脂蛋白结合,并已被认为是冠心病(CAD)的一个危险因素。
我们在一个非裔美国人和白种人群体中研究了 Lp-PLA(2)与 CAD 的关系。
在接受冠状动脉造影的 224 名非裔美国人和 336 名白种人中,测定了 Lp-PLA(2)的质量、活性和指数(一种综合衡量质量和活性的指标)以及其他心血管危险因素。
我们评估了 Lp-PLA(2)水平的分布,并确定了 Lp-PLA(2)作为 CAD 危险因素的预测作用。
与非裔美国人相比,白种人的 Lp-PLA(2)质量和活性更高(分别为 293±75 vs. 232±76ng/ml,P<0.001;分别为 173±41 vs. 141±39nmol/min/ml,P<0.001)。然而,两组的 Lp-PLA(2)指数相似(分别为 0.61±0.17 vs. 0.64±0.19,P=NS)。在两个种族群体中,CAD 患者的 Lp-PLA(2)活性和指数均显著升高。CAD 非裔美国人患者的 Lp-PLA(2)指数明显高于相应的白种人患者(0.69±0.20 vs. 0.63±0.18,P=0.028)。多元回归分析显示,在校正其他危险因素后,Lp-PLA(2)指数与非裔美国人 CAD 独立相关(比值比 6.7,P=0.047),但与白种人无关。
Lp-PLA(2)活性和指数与接受冠状动脉造影的非裔美国人和白种人 CAD 的存在相关。这些发现表明,血管炎症在非裔美国人中独立影响 CAD 风险,并强调了 Lp-PLA(2)作为心血管危险因素的重要性。